nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Ceruletide—CCKAR—obesity	0.021	1	CrCbGaD
Degarelix—GNRHR—hindbrain—obesity	0.0138	0.576	CbGeAlD
Degarelix—GNRHR—pituitary gland—obesity	0.00571	0.239	CbGeAlD
Degarelix—GNRHR—endocrine gland—obesity	0.00442	0.185	CbGeAlD
Degarelix—Dizziness—Phentermine—obesity	0.00137	0.0023	CcSEcCtD
Degarelix—Rash—Phenylpropanolamine—obesity	0.00137	0.00229	CcSEcCtD
Degarelix—Dermatitis—Phenylpropanolamine—obesity	0.00137	0.00229	CcSEcCtD
Degarelix—Body temperature increased—Cimetidine—obesity	0.00136	0.00228	CcSEcCtD
Degarelix—Abdominal discomfort—Bupropion—obesity	0.00135	0.00226	CcSEcCtD
Degarelix—Vomiting—Phentermine—obesity	0.00132	0.00221	CcSEcCtD
Degarelix—Urinary tract disorder—Orlistat—obesity	0.00132	0.00221	CcSEcCtD
Degarelix—Dysuria—Bupropion—obesity	0.00132	0.00221	CcSEcCtD
Degarelix—Oedema peripheral—Orlistat—obesity	0.00131	0.00221	CcSEcCtD
Degarelix—Urethral disorder—Orlistat—obesity	0.00131	0.0022	CcSEcCtD
Degarelix—Rash—Phentermine—obesity	0.00131	0.0022	CcSEcCtD
Degarelix—Dermatitis—Phentermine—obesity	0.00131	0.00219	CcSEcCtD
Degarelix—Headache—Phentermine—obesity	0.0013	0.00218	CcSEcCtD
Degarelix—Pollakiuria—Bupropion—obesity	0.0013	0.00218	CcSEcCtD
Degarelix—Erectile dysfunction—Bupropion—obesity	0.0013	0.00217	CcSEcCtD
Degarelix—Nausea—Phenylpropanolamine—obesity	0.00129	0.00216	CcSEcCtD
Degarelix—Hypoaesthesia—Sibutramine—obesity	0.00129	0.00216	CcSEcCtD
Degarelix—Weight increased—Bupropion—obesity	0.00128	0.00215	CcSEcCtD
Degarelix—Weight decreased—Bupropion—obesity	0.00127	0.00214	CcSEcCtD
Degarelix—Oedema peripheral—Sibutramine—obesity	0.00127	0.00214	CcSEcCtD
Degarelix—Hyperglycaemia—Bupropion—obesity	0.00127	0.00213	CcSEcCtD
Degarelix—Hypersensitivity—Cimetidine—obesity	0.00127	0.00212	CcSEcCtD
Degarelix—Mental disability—Topiramate—obesity	0.00124	0.00208	CcSEcCtD
Degarelix—Acute coronary syndrome—Bupropion—obesity	0.00124	0.00207	CcSEcCtD
Degarelix—Diarrhoea—Diethylpropion—obesity	0.00124	0.00207	CcSEcCtD
Degarelix—Nausea—Phentermine—obesity	0.00123	0.00207	CcSEcCtD
Degarelix—Asthenia—Cimetidine—obesity	0.00123	0.00207	CcSEcCtD
Degarelix—Myocardial infarction—Bupropion—obesity	0.00123	0.00206	CcSEcCtD
Degarelix—Urinary tract infection—Bupropion—obesity	0.00122	0.00205	CcSEcCtD
Degarelix—Eye disorder—Sibutramine—obesity	0.00121	0.00203	CcSEcCtD
Degarelix—Immune system disorder—Orlistat—obesity	0.00121	0.00202	CcSEcCtD
Degarelix—Mediastinal disorder—Orlistat—obesity	0.0012	0.00202	CcSEcCtD
Degarelix—Dizziness—Diethylpropion—obesity	0.00119	0.002	CcSEcCtD
Degarelix—Diabetes mellitus—Topiramate—obesity	0.00119	0.002	CcSEcCtD
Degarelix—Blood alkaline phosphatase increased—Topiramate—obesity	0.00119	0.002	CcSEcCtD
Degarelix—Alopecia—Orlistat—obesity	0.00118	0.00198	CcSEcCtD
Degarelix—Diarrhoea—Cimetidine—obesity	0.00118	0.00197	CcSEcCtD
Degarelix—Angiopathy—Sibutramine—obesity	0.00117	0.00197	CcSEcCtD
Degarelix—Mental disorder—Orlistat—obesity	0.00117	0.00196	CcSEcCtD
Degarelix—Immune system disorder—Sibutramine—obesity	0.00117	0.00196	CcSEcCtD
Degarelix—Malnutrition—Orlistat—obesity	0.00116	0.00195	CcSEcCtD
Degarelix—Chills—Sibutramine—obesity	0.00116	0.00194	CcSEcCtD
Degarelix—Arrhythmia—Sibutramine—obesity	0.00115	0.00194	CcSEcCtD
Degarelix—Vomiting—Diethylpropion—obesity	0.00115	0.00193	CcSEcCtD
Degarelix—Alopecia—Sibutramine—obesity	0.00114	0.00192	CcSEcCtD
Degarelix—Rash—Diethylpropion—obesity	0.00114	0.00191	CcSEcCtD
Degarelix—Dermatitis—Diethylpropion—obesity	0.00114	0.00191	CcSEcCtD
Degarelix—Dizziness—Cimetidine—obesity	0.00114	0.00191	CcSEcCtD
Degarelix—Headache—Diethylpropion—obesity	0.00113	0.0019	CcSEcCtD
Degarelix—Malnutrition—Sibutramine—obesity	0.00112	0.00189	CcSEcCtD
Degarelix—Back pain—Orlistat—obesity	0.00112	0.00189	CcSEcCtD
Degarelix—Hypoaesthesia—Bupropion—obesity	0.00112	0.00188	CcSEcCtD
Degarelix—Libido decreased—Topiramate—obesity	0.00112	0.00188	CcSEcCtD
Degarelix—Muscle spasms—Orlistat—obesity	0.00112	0.00187	CcSEcCtD
Degarelix—Urinary tract disorder—Bupropion—obesity	0.00111	0.00187	CcSEcCtD
Degarelix—Oedema peripheral—Bupropion—obesity	0.00111	0.00186	CcSEcCtD
Degarelix—Hot flush—Topiramate—obesity	0.00111	0.00186	CcSEcCtD
Degarelix—Urethral disorder—Bupropion—obesity	0.0011	0.00185	CcSEcCtD
Degarelix—Menopausal symptoms—Topiramate—obesity	0.0011	0.00184	CcSEcCtD
Degarelix—Vision blurred—Orlistat—obesity	0.0011	0.00184	CcSEcCtD
Degarelix—Vomiting—Cimetidine—obesity	0.00109	0.00183	CcSEcCtD
Degarelix—Back pain—Sibutramine—obesity	0.00109	0.00182	CcSEcCtD
Degarelix—Rash—Cimetidine—obesity	0.00108	0.00182	CcSEcCtD
Degarelix—Dermatitis—Cimetidine—obesity	0.00108	0.00182	CcSEcCtD
Degarelix—Muscle spasms—Sibutramine—obesity	0.00108	0.00181	CcSEcCtD
Degarelix—Ill-defined disorder—Orlistat—obesity	0.00108	0.00181	CcSEcCtD
Degarelix—Headache—Cimetidine—obesity	0.00108	0.00181	CcSEcCtD
Degarelix—Nausea—Diethylpropion—obesity	0.00107	0.0018	CcSEcCtD
Degarelix—Vision blurred—Sibutramine—obesity	0.00106	0.00178	CcSEcCtD
Degarelix—Eye disorder—Bupropion—obesity	0.00105	0.00177	CcSEcCtD
Degarelix—Malaise—Orlistat—obesity	0.00105	0.00176	CcSEcCtD
Degarelix—Cardiac disorder—Bupropion—obesity	0.00105	0.00175	CcSEcCtD
Degarelix—Ill-defined disorder—Sibutramine—obesity	0.00104	0.00175	CcSEcCtD
Degarelix—Anaemia—Sibutramine—obesity	0.00104	0.00174	CcSEcCtD
Degarelix—Disturbance in sexual arousal—Topiramate—obesity	0.00103	0.00173	CcSEcCtD
Degarelix—Palpitations—Orlistat—obesity	0.00103	0.00172	CcSEcCtD
Degarelix—Angiopathy—Bupropion—obesity	0.00102	0.00171	CcSEcCtD
Degarelix—Nausea—Cimetidine—obesity	0.00102	0.00171	CcSEcCtD
Degarelix—Immune system disorder—Bupropion—obesity	0.00102	0.00171	CcSEcCtD
Degarelix—Mediastinal disorder—Bupropion—obesity	0.00101	0.0017	CcSEcCtD
Degarelix—Malaise—Sibutramine—obesity	0.00101	0.0017	CcSEcCtD
Degarelix—Chills—Bupropion—obesity	0.00101	0.0017	CcSEcCtD
Degarelix—Arrhythmia—Bupropion—obesity	0.00101	0.00169	CcSEcCtD
Degarelix—Alopecia—Bupropion—obesity	0.000995	0.00167	CcSEcCtD
Degarelix—Palpitations—Sibutramine—obesity	0.000994	0.00167	CcSEcCtD
Degarelix—Mental disorder—Bupropion—obesity	0.000987	0.00166	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000982	0.00165	CcSEcCtD
Degarelix—Malnutrition—Bupropion—obesity	0.00098	0.00164	CcSEcCtD
Degarelix—Discomfort—Orlistat—obesity	0.000977	0.00164	CcSEcCtD
Degarelix—Hypertension—Sibutramine—obesity	0.000971	0.00163	CcSEcCtD
Degarelix—Dry mouth—Orlistat—obesity	0.000967	0.00162	CcSEcCtD
Degarelix—Arthralgia—Sibutramine—obesity	0.000957	0.00161	CcSEcCtD
Degarelix—Anaphylactic shock—Orlistat—obesity	0.000948	0.00159	CcSEcCtD
Degarelix—Back pain—Bupropion—obesity	0.000948	0.00159	CcSEcCtD
Degarelix—Discomfort—Sibutramine—obesity	0.000946	0.00159	CcSEcCtD
Degarelix—Muscle spasms—Bupropion—obesity	0.000942	0.00158	CcSEcCtD
Degarelix—Breast disorder—Topiramate—obesity	0.000937	0.00157	CcSEcCtD
Degarelix—Dry mouth—Sibutramine—obesity	0.000936	0.00157	CcSEcCtD
Degarelix—Nervous system disorder—Orlistat—obesity	0.00093	0.00156	CcSEcCtD
Degarelix—Vision blurred—Bupropion—obesity	0.000924	0.00155	CcSEcCtD
Degarelix—Skin disorder—Orlistat—obesity	0.000921	0.00155	CcSEcCtD
Degarelix—Anaphylactic shock—Sibutramine—obesity	0.000918	0.00154	CcSEcCtD
Degarelix—Hyperhidrosis—Orlistat—obesity	0.000917	0.00154	CcSEcCtD
Degarelix—Muscular weakness—Topiramate—obesity	0.000915	0.00153	CcSEcCtD
Degarelix—Ill-defined disorder—Bupropion—obesity	0.00091	0.00153	CcSEcCtD
Degarelix—Anaemia—Bupropion—obesity	0.000906	0.00152	CcSEcCtD
Degarelix—Skin disorder—Sibutramine—obesity	0.000891	0.0015	CcSEcCtD
Degarelix—Hyperhidrosis—Sibutramine—obesity	0.000887	0.00149	CcSEcCtD
Degarelix—Malaise—Bupropion—obesity	0.000884	0.00148	CcSEcCtD
Degarelix—Palpitations—Bupropion—obesity	0.000866	0.00145	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Orlistat—obesity	0.000864	0.00145	CcSEcCtD
Degarelix—Abdominal discomfort—Topiramate—obesity	0.000859	0.00144	CcSEcCtD
Degarelix—Insomnia—Orlistat—obesity	0.000858	0.00144	CcSEcCtD
Degarelix—Hypotension—Sibutramine—obesity	0.000858	0.00144	CcSEcCtD
Degarelix—Hypertension—Bupropion—obesity	0.000846	0.00142	CcSEcCtD
Degarelix—Dysuria—Topiramate—obesity	0.000838	0.00141	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—HCRT—obesity	0.000838	0.00233	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PMCH—obesity	0.000838	0.00233	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NMU—obesity	0.000838	0.00233	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY5R—obesity	0.000838	0.00233	CbGpPWpGaD
Degarelix—Musculoskeletal discomfort—Sibutramine—obesity	0.000836	0.0014	CcSEcCtD
Degarelix—Arthralgia—Bupropion—obesity	0.000835	0.0014	CcSEcCtD
Degarelix—Insomnia—Sibutramine—obesity	0.00083	0.00139	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000829	0.00139	CcSEcCtD
Degarelix—Pollakiuria—Topiramate—obesity	0.000828	0.00139	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	0.000826	0.0023	CbGpPWpGaD
Degarelix—Erectile dysfunction—Topiramate—obesity	0.000826	0.00139	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.000825	0.0023	CbGpPWpGaD
Degarelix—Discomfort—Bupropion—obesity	0.000825	0.00138	CcSEcCtD
Degarelix—Decreased appetite—Orlistat—obesity	0.000824	0.00138	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—MKS1—obesity	0.00082	0.00228	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—KIF7—obesity	0.00082	0.00228	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Orlistat—obesity	0.000819	0.00137	CcSEcCtD
Degarelix—Dyspnoea—Sibutramine—obesity	0.000818	0.00137	CcSEcCtD
Degarelix—Fatigue—Orlistat—obesity	0.000818	0.00137	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—NPS—obesity	0.000816	0.00227	CbGpPWpGaD
Degarelix—Dry mouth—Bupropion—obesity	0.000816	0.00137	CcSEcCtD
Degarelix—Weight increased—Topiramate—obesity	0.000816	0.00137	CcSEcCtD
Degarelix—Weight decreased—Topiramate—obesity	0.000811	0.00136	CcSEcCtD
Degarelix—Pain—Orlistat—obesity	0.000811	0.00136	CcSEcCtD
Degarelix—Hyperglycaemia—Topiramate—obesity	0.000809	0.00136	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—MC4R—obesity	0.000803	0.00224	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—MC3R—obesity	0.000803	0.00224	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY1R—obesity	0.000803	0.00224	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY2R—obesity	0.000803	0.00224	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—DRD1—obesity	0.000801	0.00223	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2C—obesity	0.000801	0.00223	CbGpPWpGaD
Degarelix—Anaphylactic shock—Bupropion—obesity	0.0008	0.00134	CcSEcCtD
Degarelix—Decreased appetite—Sibutramine—obesity	0.000798	0.00134	CcSEcCtD
Degarelix—Depression—Topiramate—obesity	0.000797	0.00134	CcSEcCtD
Degarelix—Gastrointestinal disorder—Sibutramine—obesity	0.000792	0.00133	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—PPY—obesity	0.000788	0.00219	CbGpPWpGaD
Degarelix—Renal failure—Topiramate—obesity	0.000786	0.00132	CcSEcCtD
Degarelix—Constipation—Sibutramine—obesity	0.000785	0.00132	CcSEcCtD
Degarelix—Pain—Sibutramine—obesity	0.000785	0.00132	CcSEcCtD
Degarelix—Nervous system disorder—Bupropion—obesity	0.000785	0.00132	CcSEcCtD
Degarelix—Feeling abnormal—Orlistat—obesity	0.000781	0.00131	CcSEcCtD
Degarelix—Skin disorder—Bupropion—obesity	0.000777	0.0013	CcSEcCtD
Degarelix—Urinary tract infection—Topiramate—obesity	0.000777	0.0013	CcSEcCtD
Degarelix—Gastrointestinal pain—Orlistat—obesity	0.000775	0.0013	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—ADRB1—obesity	0.000775	0.00216	CbGpPWpGaD
Degarelix—Hyperhidrosis—Bupropion—obesity	0.000773	0.0013	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GIP—obesity	0.000773	0.00215	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PRKCH—obesity	0.000773	0.00215	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	0.000764	0.00213	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HCRT—obesity	0.000761	0.00212	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PMCH—obesity	0.000761	0.00212	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NMU—obesity	0.000761	0.00212	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY5R—obesity	0.000761	0.00212	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GHRL—obesity	0.000759	0.00211	CbGpPWpGaD
Degarelix—Feeling abnormal—Sibutramine—obesity	0.000756	0.00127	CcSEcCtD
Degarelix—Urticaria—Orlistat—obesity	0.000753	0.00126	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—DRD4—obesity	0.000753	0.0021	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Sibutramine—obesity	0.00075	0.00126	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PRLH—obesity	0.00075	0.00209	CbGpPWpGaD
Degarelix—Body temperature increased—Orlistat—obesity	0.00075	0.00126	CcSEcCtD
Degarelix—Abdominal pain—Orlistat—obesity	0.00075	0.00126	CcSEcCtD
Degarelix—Hypotension—Bupropion—obesity	0.000748	0.00125	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000731	0.00204	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY1R—obesity	0.000729	0.00203	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MC3R—obesity	0.000729	0.00203	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—MC4R—obesity	0.000729	0.00203	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY2R—obesity	0.000729	0.00203	CbGpPWpGaD
Degarelix—Urticaria—Sibutramine—obesity	0.000729	0.00122	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Bupropion—obesity	0.000729	0.00122	CcSEcCtD
Degarelix—Abdominal pain—Sibutramine—obesity	0.000725	0.00122	CcSEcCtD
Degarelix—Body temperature increased—Sibutramine—obesity	0.000725	0.00122	CcSEcCtD
Degarelix—Insomnia—Bupropion—obesity	0.000724	0.00121	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CNR1—obesity	0.000719	0.002	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PPY—obesity	0.000715	0.00199	CbGpPWpGaD
Degarelix—Hypoaesthesia—Topiramate—obesity	0.000714	0.0012	CcSEcCtD
Degarelix—Dyspnoea—Bupropion—obesity	0.000713	0.0012	CcSEcCtD
Degarelix—Urinary tract disorder—Topiramate—obesity	0.000709	0.00119	CcSEcCtD
Degarelix—Oedema peripheral—Topiramate—obesity	0.000707	0.00119	CcSEcCtD
Degarelix—Urethral disorder—Topiramate—obesity	0.000703	0.00118	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—PRKCH—obesity	0.000702	0.00196	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GIP—obesity	0.000702	0.00196	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—DRD2—obesity	0.000701	0.00195	CbGpPWpGaD
Degarelix—Hypersensitivity—Orlistat—obesity	0.000699	0.00117	CcSEcCtD
Degarelix—Decreased appetite—Bupropion—obesity	0.000695	0.00117	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—GCG—obesity	0.000694	0.00193	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Bupropion—obesity	0.000691	0.00116	CcSEcCtD
Degarelix—Fatigue—Bupropion—obesity	0.00069	0.00116	CcSEcCtD
Degarelix—Pain—Bupropion—obesity	0.000684	0.00115	CcSEcCtD
Degarelix—Constipation—Bupropion—obesity	0.000684	0.00115	CcSEcCtD
Degarelix—Asthenia—Orlistat—obesity	0.00068	0.00114	CcSEcCtD
Degarelix—GNRHR—G alpha (q) signalling events—PIK3R1—obesity	0.000678	0.00189	CbGpPWpGaD
Degarelix—Hypersensitivity—Sibutramine—obesity	0.000676	0.00113	CcSEcCtD
Degarelix—Pruritus—Orlistat—obesity	0.000671	0.00113	CcSEcCtD
Degarelix—Eye disorder—Topiramate—obesity	0.00067	0.00112	CcSEcCtD
Degarelix—Cardiac disorder—Topiramate—obesity	0.000666	0.00112	CcSEcCtD
Degarelix—Feeling abnormal—Bupropion—obesity	0.000659	0.00111	CcSEcCtD
Degarelix—Asthenia—Sibutramine—obesity	0.000658	0.0011	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—ADRB3—obesity	0.000657	0.00183	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Bupropion—obesity	0.000654	0.0011	CcSEcCtD
Degarelix—Angiopathy—Topiramate—obesity	0.000651	0.00109	CcSEcCtD
Degarelix—Pruritus—Sibutramine—obesity	0.000649	0.00109	CcSEcCtD
Degarelix—Diarrhoea—Orlistat—obesity	0.000649	0.00109	CcSEcCtD
Degarelix—Immune system disorder—Topiramate—obesity	0.000648	0.00109	CcSEcCtD
Degarelix—Mediastinal disorder—Topiramate—obesity	0.000647	0.00108	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000645	0.0018	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000644	0.00179	CbGpPWpGaD
Degarelix—Chills—Topiramate—obesity	0.000644	0.00108	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GAL—obesity	0.000642	0.00179	CbGpPWpGaD
Degarelix—Urticaria—Bupropion—obesity	0.000636	0.00107	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—C5AR1—obesity	0.000635	0.00177	CbGpPWpGaD
Degarelix—Alopecia—Topiramate—obesity	0.000634	0.00106	CcSEcCtD
Degarelix—Abdominal pain—Bupropion—obesity	0.000632	0.00106	CcSEcCtD
Degarelix—Body temperature increased—Bupropion—obesity	0.000632	0.00106	CcSEcCtD
Degarelix—Mental disorder—Topiramate—obesity	0.000629	0.00105	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—ADRB2—obesity	0.000628	0.00175	CbGpPWpGaD
Degarelix—Diarrhoea—Sibutramine—obesity	0.000628	0.00105	CcSEcCtD
Degarelix—Dizziness—Orlistat—obesity	0.000627	0.00105	CcSEcCtD
Degarelix—Erythema—Topiramate—obesity	0.000625	0.00105	CcSEcCtD
Degarelix—Malnutrition—Topiramate—obesity	0.000625	0.00105	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—NMB—obesity	0.000622	0.00173	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GHRH—obesity	0.000622	0.00173	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	0.000618	0.00172	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.000612	0.0017	CbGpPWpGaD
Degarelix—Dizziness—Sibutramine—obesity	0.000607	0.00102	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	0.000607	0.00169	CbGpPWpGaD
Degarelix—Back pain—Topiramate—obesity	0.000604	0.00101	CcSEcCtD
Degarelix—Vomiting—Orlistat—obesity	0.000603	0.00101	CcSEcCtD
Degarelix—Muscle spasms—Topiramate—obesity	0.0006	0.00101	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—GNB3—obesity	0.000598	0.00167	CbGpPWpGaD
Degarelix—Rash—Orlistat—obesity	0.000598	0.001	CcSEcCtD
Degarelix—Dermatitis—Orlistat—obesity	0.000597	0.001	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—ADRB3—obesity	0.000597	0.00166	CbGpPWpGaD
Degarelix—Headache—Orlistat—obesity	0.000594	0.000997	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—FFAR4—obesity	0.000593	0.00165	CbGpPWpGaD
Degarelix—Hypersensitivity—Bupropion—obesity	0.000589	0.000989	CcSEcCtD
Degarelix—Vision blurred—Topiramate—obesity	0.000589	0.000988	CcSEcCtD
Degarelix—Vomiting—Sibutramine—obesity	0.000583	0.000979	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—GAL—obesity	0.000583	0.00162	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GNAS—obesity	0.000583	0.00162	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCK—obesity	0.000581	0.00162	CbGpPWpGaD
Degarelix—Ill-defined disorder—Topiramate—obesity	0.000579	0.000972	CcSEcCtD
Degarelix—Rash—Sibutramine—obesity	0.000579	0.000971	CcSEcCtD
Degarelix—Dermatitis—Sibutramine—obesity	0.000578	0.00097	CcSEcCtD
Degarelix—Anaemia—Topiramate—obesity	0.000577	0.000969	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—C5AR1—obesity	0.000577	0.00161	CbGpPWpGaD
Degarelix—Headache—Sibutramine—obesity	0.000575	0.000965	CcSEcCtD
Degarelix—Asthenia—Bupropion—obesity	0.000574	0.000963	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GHSR—obesity	0.000569	0.00158	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—BRS3—obesity	0.000569	0.00158	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MCHR1—obesity	0.000569	0.00158	CbGpPWpGaD
Degarelix—Pruritus—Bupropion—obesity	0.000566	0.00095	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GLP1R—obesity	0.000566	0.00158	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000565	0.00157	CbGpPWpGaD
Degarelix—Nausea—Orlistat—obesity	0.000563	0.000945	CcSEcCtD
Degarelix—Malaise—Topiramate—obesity	0.000563	0.000945	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—CCL5—obesity	0.000557	0.00155	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HRH3—obesity	0.000557	0.00155	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCKAR—obesity	0.000557	0.00155	CbGpPWpGaD
Degarelix—Palpitations—Topiramate—obesity	0.000552	0.000926	CcSEcCtD
Degarelix—Diarrhoea—Bupropion—obesity	0.000547	0.000918	CcSEcCtD
Degarelix—Nausea—Sibutramine—obesity	0.000545	0.000915	CcSEcCtD
Degarelix—Hypertension—Topiramate—obesity	0.000539	0.000905	CcSEcCtD
Degarelix—Arthralgia—Topiramate—obesity	0.000532	0.000892	CcSEcCtD
Degarelix—Dizziness—Bupropion—obesity	0.000529	0.000888	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PRLHR—obesity	0.000529	0.00147	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GH1—obesity	0.000529	0.00147	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SH2B1—obesity	0.000529	0.00147	CbGpPWpGaD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000528	0.000886	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCK—obesity	0.000527	0.00147	CbGpPWpGaD
Degarelix—Discomfort—Topiramate—obesity	0.000525	0.000881	CcSEcCtD
Degarelix—Dry mouth—Topiramate—obesity	0.00052	0.000873	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000515	0.00143	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GLP1R—obesity	0.000514	0.00143	CbGpPWpGaD
Degarelix—Vomiting—Bupropion—obesity	0.000509	0.000853	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HRH3—obesity	0.000506	0.00141	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCKAR—obesity	0.000506	0.00141	CbGpPWpGaD
Degarelix—Rash—Bupropion—obesity	0.000504	0.000846	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—NPY—obesity	0.000504	0.0014	CbGpPWpGaD
Degarelix—Dermatitis—Bupropion—obesity	0.000504	0.000846	CcSEcCtD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000504	0.0014	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—IAPP—obesity	0.000501	0.0014	CbGpPWpGaD
Degarelix—Headache—Bupropion—obesity	0.000501	0.000841	CcSEcCtD
Degarelix—Nervous system disorder—Topiramate—obesity	0.0005	0.000839	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—APLN—obesity	0.000497	0.00138	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PYY—obesity	0.000497	0.00138	CbGpPWpGaD
Degarelix—Skin disorder—Topiramate—obesity	0.000495	0.000831	CcSEcCtD
Degarelix—Hyperhidrosis—Topiramate—obesity	0.000493	0.000827	CcSEcCtD
Degarelix—GNRHR—GPCR ligand binding—HTR2A—obesity	0.000491	0.00137	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—C3—obesity	0.00049	0.00137	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKAR2B—obesity	0.000487	0.00136	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR1B—obesity	0.000487	0.00136	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CRH—obesity	0.000487	0.00136	CbGpPWpGaD
Degarelix—Hypotension—Topiramate—obesity	0.000476	0.000799	CcSEcCtD
Degarelix—Nausea—Bupropion—obesity	0.000475	0.000797	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PNLIP—obesity	0.000471	0.00131	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AGT—obesity	0.000466	0.0013	CbGpPWpGaD
Degarelix—Musculoskeletal discomfort—Topiramate—obesity	0.000464	0.000779	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—NPS—obesity	0.000461	0.00128	CbGpPWpGaD
Degarelix—Insomnia—Topiramate—obesity	0.000461	0.000774	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—SDC3—obesity	0.00046	0.00128	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY—obesity	0.000458	0.00128	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IAPP—obesity	0.000455	0.00127	CbGpPWpGaD
Degarelix—Dyspnoea—Topiramate—obesity	0.000454	0.000762	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—DRD1—obesity	0.000452	0.00126	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2C—obesity	0.000452	0.00126	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HCRT—obesity	0.000449	0.00125	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PMCH—obesity	0.000449	0.00125	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPY5R—obesity	0.000449	0.00125	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NMU—obesity	0.000449	0.00125	CbGpPWpGaD
Degarelix—Decreased appetite—Topiramate—obesity	0.000443	0.000743	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CRH—obesity	0.000442	0.00123	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR1B—obesity	0.000442	0.00123	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Topiramate—obesity	0.00044	0.000738	CcSEcCtD
Degarelix—Fatigue—Topiramate—obesity	0.000439	0.000737	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—ADRB1—obesity	0.000438	0.00122	CbGpPWpGaD
Degarelix—Pain—Topiramate—obesity	0.000436	0.000731	CcSEcCtD
Degarelix—Constipation—Topiramate—obesity	0.000436	0.000731	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—NPY2R—obesity	0.000431	0.0012	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MC3R—obesity	0.000431	0.0012	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPY1R—obesity	0.000431	0.0012	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MC4R—obesity	0.000431	0.0012	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—F2—obesity	0.000431	0.0012	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GHRL—obesity	0.000429	0.00119	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—DRD4—obesity	0.000425	0.00118	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PPY—obesity	0.000423	0.00118	CbGpPWpGaD
Degarelix—Feeling abnormal—Topiramate—obesity	0.00042	0.000705	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—NPS—obesity	0.000419	0.00117	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Topiramate—obesity	0.000417	0.000699	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PRKCH—obesity	0.000415	0.00116	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HDAC8—obesity	0.000415	0.00116	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GIP—obesity	0.000415	0.00116	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—DRD1—obesity	0.000411	0.00114	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR2C—obesity	0.000411	0.00114	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CNR1—obesity	0.000406	0.00113	CbGpPWpGaD
Degarelix—Urticaria—Topiramate—obesity	0.000405	0.000679	CcSEcCtD
Degarelix—Body temperature increased—Topiramate—obesity	0.000403	0.000676	CcSEcCtD
Degarelix—Abdominal pain—Topiramate—obesity	0.000403	0.000676	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—ADRB1—obesity	0.000398	0.00111	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—DRD2—obesity	0.000396	0.0011	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LEPR—obesity	0.000394	0.0011	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GCG—obesity	0.000392	0.00109	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—POMC—obesity	0.000392	0.00109	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GHRL—obesity	0.000389	0.00108	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—DRD4—obesity	0.000386	0.00108	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL2—obesity	0.000384	0.00107	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—PIK3CA—obesity	0.000382	0.00106	CbGpPWpGaD
Degarelix—Hypersensitivity—Topiramate—obesity	0.000376	0.00063	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CNR1—obesity	0.000369	0.00103	CbGpPWpGaD
Degarelix—Asthenia—Topiramate—obesity	0.000366	0.000614	CcSEcCtD
Degarelix—Pruritus—Topiramate—obesity	0.000361	0.000605	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—DRD2—obesity	0.00036	0.001	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GCG—obesity	0.000356	0.000992	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ADRB2—obesity	0.000355	0.000989	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ADRB3—obesity	0.000353	0.000982	CbGpPWpGaD
Degarelix—Diarrhoea—Topiramate—obesity	0.000349	0.000585	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GAL—obesity	0.000344	0.000959	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000341	0.000951	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—C5AR1—obesity	0.000341	0.000949	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GNB3—obesity	0.000338	0.000942	CbGpPWpGaD
Degarelix—Dizziness—Topiramate—obesity	0.000337	0.000566	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—GNAS—obesity	0.000329	0.000917	CbGpPWpGaD
Degarelix—Vomiting—Topiramate—obesity	0.000324	0.000544	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—ADRB2—obesity	0.000322	0.000898	CbGpPWpGaD
Degarelix—Rash—Topiramate—obesity	0.000321	0.000539	CcSEcCtD
Degarelix—Dermatitis—Topiramate—obesity	0.000321	0.000539	CcSEcCtD
Degarelix—Headache—Topiramate—obesity	0.000319	0.000536	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCL5—obesity	0.000315	0.000877	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKG1—obesity	0.000312	0.000868	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCK—obesity	0.000312	0.000868	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GNB3—obesity	0.000307	0.000855	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RBP4—obesity	0.000304	0.000846	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GLP1R—obesity	0.000304	0.000846	CbGpPWpGaD
Degarelix—Nausea—Topiramate—obesity	0.000303	0.000508	CcSEcCtD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000302	0.000842	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GNAS—obesity	0.000299	0.000833	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCKAR—obesity	0.000299	0.000832	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HRH3—obesity	0.000299	0.000832	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKAR2B—obesity	0.000287	0.000801	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL5—obesity	0.000286	0.000796	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PRKCD—obesity	0.000284	0.00079	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NCF2—obesity	0.000278	0.000773	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2A—obesity	0.000278	0.000773	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—C3—obesity	0.000277	0.000772	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPY—obesity	0.000271	0.000754	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IAPP—obesity	0.000269	0.000749	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOC3—obesity	0.000269	0.000749	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AGT—obesity	0.000263	0.000733	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CRH—obesity	0.000261	0.000727	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR1B—obesity	0.000261	0.000727	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SDC1—obesity	0.000258	0.000719	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKCD—obesity	0.000258	0.000717	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKR1C3—obesity	0.000254	0.000707	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR2A—obesity	0.000252	0.000702	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—C3—obesity	0.000252	0.000701	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPS—obesity	0.000247	0.000689	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PRKCB—obesity	0.000243	0.000678	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—F2—obesity	0.000243	0.000678	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—DRD1—obesity	0.000243	0.000676	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR2C—obesity	0.000243	0.000676	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AGT—obesity	0.000239	0.000666	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NTRK2—obesity	0.000236	0.000658	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ADRB1—obesity	0.000235	0.000655	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3CG—obesity	0.000233	0.000649	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GHRL—obesity	0.00023	0.000641	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PARP1—obesity	0.00023	0.000641	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—DRD4—obesity	0.000228	0.000636	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—POMC—obesity	0.000222	0.000617	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKCB—obesity	0.000221	0.000615	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—F2—obesity	0.000221	0.000615	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CNR1—obesity	0.000218	0.000607	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TCF7L2—obesity	0.000214	0.000596	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT2—obesity	0.000213	0.000593	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—DRD2—obesity	0.000213	0.000592	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3CG—obesity	0.000211	0.000589	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PTPN1—obesity	0.00021	0.000586	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GCG—obesity	0.00021	0.000586	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3CD—obesity	0.000205	0.00057	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—POMC—obesity	0.000201	0.000561	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRL—obesity	0.000201	0.000559	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—STK11—obesity	0.000198	0.000551	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL2—obesity	0.000197	0.000548	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PLG—obesity	0.000196	0.000545	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—RHOA—obesity	0.000195	0.000544	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT2—obesity	0.000193	0.000539	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3R1—obesity	0.000193	0.000538	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—FOXO3—obesity	0.000191	0.000532	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ADRB2—obesity	0.00019	0.00053	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SOCS1—obesity	0.000188	0.000522	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3CD—obesity	0.000186	0.000518	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SOCS3—obesity	0.000185	0.000516	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GNB3—obesity	0.000181	0.000505	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—TYK2—obesity	0.000179	0.000498	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3CB—obesity	0.000178	0.000497	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF2—obesity	0.000178	0.000496	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—RHOA—obesity	0.000177	0.000494	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GNAS—obesity	0.000177	0.000492	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3R1—obesity	0.000176	0.000489	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOB—obesity	0.000173	0.000482	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL5—obesity	0.000169	0.00047	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LPL—obesity	0.000165	0.00046	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—FOXO1—obesity	0.000164	0.000457	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RPS6KB1—obesity	0.000164	0.000456	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3CB—obesity	0.000162	0.000451	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKCD—obesity	0.000152	0.000424	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—HTR2A—obesity	0.000149	0.000415	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—C3—obesity	0.000149	0.000414	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IRS2—obesity	0.000141	0.000394	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AGT—obesity	0.000141	0.000393	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOE—obesity	0.000138	0.000385	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—LEP—obesity	0.000138	0.000385	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CAV1—obesity	0.000137	0.000382	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOA1—obesity	0.000137	0.000381	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ESR1—obesity	0.000132	0.000368	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—F2—obesity	0.000131	0.000364	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKCB—obesity	0.000131	0.000364	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—BAD—obesity	0.000129	0.000359	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3CG—obesity	0.000125	0.000348	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IRS1—obesity	0.000123	0.000344	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—POMC—obesity	0.000119	0.000331	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—INS—obesity	0.000118	0.000329	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL2—obesity	0.000116	0.000324	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IGF1—obesity	0.000114	0.000319	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT2—obesity	0.000114	0.000318	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3CD—obesity	0.00011	0.000306	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PIK3CA—obesity	0.000109	0.000303	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SERPINE1—obesity	0.000109	0.000302	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TYK2—obesity	0.000106	0.000294	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RHOA—obesity	0.000105	0.000292	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3R1—obesity	0.000104	0.000289	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NOS3—obesity	0.000104	0.000289	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PIK3CA—obesity	9.88e-05	0.000275	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MTOR—obesity	9.57e-05	0.000267	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3CB—obesity	9.57e-05	0.000267	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT1—obesity	8.89e-05	0.000247	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—IL6—obesity	8.75e-05	0.000244	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MMP9—obesity	8.32e-05	0.000232	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MAPK8—obesity	8.09e-05	0.000225	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT1—obesity	8.07e-05	0.000225	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—STAT3—obesity	7.4e-05	0.000206	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MYC—obesity	6.87e-05	0.000191	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TGFB1—obesity	6.86e-05	0.000191	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PIK3CA—obesity	5.83e-05	0.000163	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6—obesity	5.17e-05	0.000144	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT1—obesity	4.77e-05	0.000133	CbGpPWpGaD
